546 related articles for article (PubMed ID: 17014881)
21. Preserved antigenicity of HIV-1 p24 produced and purified in high yields from plants inoculated with a tobacco mosaic virus (TMV)-derived vector.
Pérez-Filgueira DM; Brayfield BP; Phiri S; Borca MV; Wood C; Morris TJ
J Virol Methods; 2004 Nov; 121(2):201-8. PubMed ID: 15381357
[TBL] [Abstract][Full Text] [Related]
22. Development of a new noncytopathic Semliki Forest virus vector providing high expression levels and stability.
Casales E; Rodriguez-Madoz JR; Ruiz-Guillen M; Razquin N; Cuevas Y; Prieto J; Smerdou C
Virology; 2008 Jun; 376(1):242-51. PubMed ID: 18442838
[TBL] [Abstract][Full Text] [Related]
23. High-level expression of rabies virus glycoprotein with the RNA-based Semliki Forest Virus expression vector.
Benmaamar R; Astray RM; Wagner R; Pereira CA
J Biotechnol; 2009 Feb; 139(4):283-90. PubMed ID: 19135103
[TBL] [Abstract][Full Text] [Related]
24. A vaccination strategy consisting of Semliki-Forest-virus (SFV) DNA prime and fowlpox-virus boost significantly protects mice from a recombinant (HIV-1) vaccinia-virus infection.
Quintana-Vázquez D; Vázquez-Blomquist DM; Galbán Rodríguez E; Herrera Buch AM; Duarte Cano CA
Biotechnol Appl Biochem; 2005 Feb; 41(Pt 1):59-66. PubMed ID: 15099194
[TBL] [Abstract][Full Text] [Related]
25. Expression of mammalian membrane proteins in mammalian cells using Semliki Forest virus vectors.
Lundstrom K
Methods Mol Biol; 2010; 601():149-63. PubMed ID: 20099145
[TBL] [Abstract][Full Text] [Related]
26. Semliki Forest virus is an efficient and selective vector for gene delivery in infarcted rat heart.
Loot AE; Henning RH; Deelman LE; Tio RA; Schoen P; Wilschut JC; van Gilst WH; Roks AJ
J Mol Cell Cardiol; 2004 Jul; 37(1):137-42. PubMed ID: 15242744
[TBL] [Abstract][Full Text] [Related]
27. Immunogenicity and protective efficacy of Semliki forest virus replicon-based DNA vaccines encoding goatpox virus structural proteins.
Zheng M; Jin N; Liu Q; Huo X; Li Y; Hu B; Ma H; Zhu Z; Cong Y; Li X; Jin M; Zhu G
Virology; 2009 Aug; 391(1):33-43. PubMed ID: 19559453
[TBL] [Abstract][Full Text] [Related]
28. Analysis of human immunodeficiency virus type 1 vector cis- and trans-acting elements production by means of Semliki Forest virus.
Del Vecchio C; Calistri A; Lombardi G; Celegato M; Biasolo MA; Palù G; Parolin C
Gene Ther; 2009 Feb; 16(2):279-90. PubMed ID: 19037240
[TBL] [Abstract][Full Text] [Related]
29. [Difference in the mechanism of self-assembly in vitro in tobacco mosaic virus and potato virus X].
Gol'dshteĭn MI; Kust SV; Dobrov EN
Mol Gen Mikrobiol Virusol; 1987 Dec; (12):45-8. PubMed ID: 3447057
[TBL] [Abstract][Full Text] [Related]
30. Regulation of Semliki Forest virus RNA replication: a model for the control of alphavirus pathogenesis in invertebrate hosts.
Kim KH; Rümenapf T; Strauss EG; Strauss JH
Virology; 2004 May; 323(1):153-63. PubMed ID: 15165827
[TBL] [Abstract][Full Text] [Related]
31. Packaging of tobacco mosaic virus subgenomic RNAs by Brome mosaic virus coat protein exhibits RNA controlled polymorphism.
Choi YG; Rao AL
Virology; 2000 Sep; 275(2):249-57. PubMed ID: 10998324
[TBL] [Abstract][Full Text] [Related]
32. Encapsidation of genomic but not subgenomic Turnip yellow mosaic virus RNA by coat protein provided in trans.
Cho TJ; Dreher TW
Virology; 2006 Dec 5-20; 356(1-2):126-35. PubMed ID: 16942786
[TBL] [Abstract][Full Text] [Related]
33. A modified TMV-based vector facilitates the expression of longer foreign epitopes in tobacco.
Jiang L; Li Q; Li M; Zhou Z; Wu L; Fan J; Zhang Q; Zhu H; Xu Z
Vaccine; 2006 Jan; 24(2):109-15. PubMed ID: 16337317
[TBL] [Abstract][Full Text] [Related]
34. Semliki forest virus vectors engineered to express higher IL-12 levels induce efficient elimination of murine colon adenocarcinomas.
Rodriguez-Madoz JR; Prieto J; Smerdou C
Mol Ther; 2005 Jul; 12(1):153-63. PubMed ID: 15963931
[TBL] [Abstract][Full Text] [Related]
35. Co-expression of multiple target proteins in plants from a tobacco mosaic virus vector using a combination of homologous and heterologous subgenomic promoters.
Roy G; Weisburg S; Foy K; Rabindran S; Mett V; Yusibov V
Arch Virol; 2011 Nov; 156(11):2057-61. PubMed ID: 21779909
[TBL] [Abstract][Full Text] [Related]
36. [Construction of DNA and RNA based on bifunctional replicon vector derived from Semliki Forest virus].
Yu YZ; Sun ZW; Yu WY
Sheng Wu Gong Cheng Xue Bao; 2005 Sep; 21(5):713-8. PubMed ID: 16285510
[TBL] [Abstract][Full Text] [Related]
37. Assembly of viroplasm and virus-like particles of rotavirus by a Semliki Forest virus replicon.
Nilsson M; von Bonsdorff CH; Weclewicz K; Cohen J; Svensson L
Virology; 1998 Mar; 242(2):255-65. PubMed ID: 9514960
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic and prophylactic applications of alphavirus vectors.
Atkins GJ; Fleeton MN; Sheahan BJ
Expert Rev Mol Med; 2008 Nov; 10():e33. PubMed ID: 19000329
[TBL] [Abstract][Full Text] [Related]
39. Augmentation of alphavirus vector-induced human papilloma virus-specific immune and anti-tumour responses by co-expression of interleukin-12.
Riezebos-Brilman A; Regts J; Chen M; Wilschut J; Daemen T
Vaccine; 2009 Jan; 27(5):701-7. PubMed ID: 19041356
[TBL] [Abstract][Full Text] [Related]
40. A Semliki forest virus vector engineered to express IFNα induces efficient elimination of established tumors.
Quetglas JI; Fioravanti J; Ardaiz N; Medina-Echeverz J; Baraibar I; Prieto J; Smerdou C; Berraondo P
Gene Ther; 2012 Mar; 19(3):271-8. PubMed ID: 21734727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
